# Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

> clinical trial · VERIFIED · 2026-07-17

Status: ACTIVE_NOT_RECRUITING · Sponsor: UNICANCER · Condition: Lung Cancer Metastatic

- Company: UNICANCER
- Sector: Lung Cancer Metastatic
- Primary source: https://clinicaltrials.gov/study/NCT05078047

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.